Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
A genome-wide association study of brain lesion distribution in multiple sclerosis.
Pharmacokinetic properties and metabolism of idebenone.
8th FENS Forum of Neuroscience
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Application of fullerenes in nanomedicine: an update.
Biogen Reports Another Tecfidera PML Case
ALSUntangled No. 8: Low dose naltrexone for ALS.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Bruxism and temporal bone hypermobility in patients with multiple sclerosis.
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study.
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.
Imaging Neurodegeneration and Repair in Multiple Sclerosis
Ofatumumab
Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab.
Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke.
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.

Pages